Repligen | RGEN - 资产



金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 606.78M
销售成本
USD 94.09M
流动资产
USD 1.2B
流动负债
USD 132.66M
债务
USD 690.94M
EBIT
USD 21.13M
EBITDA
USD 43.77M
员工
1.78K
EPS每股收益
USD 0.54
股本和储备
USD 2.11B
销售毛利
USD 110.04M
债务利息支出
USD 5.66M
利息收入
USD 7.31M
贷款资金
USD 551.05M
市值
USD 9.27B
净收入
USD 5.01M
营业费用
USD 183M
营业利润
USD 21.13M
普通股股本
USD 56.43M
PE价格收益
105.09
税前利润
USD 14.15M
销售收入
USD 204M
销售和管理费用
USD 76.62M
股票
USD 186.6M
贸易债权人
USD 33.23M
应收帐款人
USD 157.71M


资产 更改 日
Agilent USD 13.07B 252M 2026-03
Align Technology USD 6.42B 103.41M 2026-06
Bio Techne USD 2.55B 27.9M 2026-03
BioMarin Pharmaceutical USD 11.72B 3.13B 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Bruker USD 6.05B 77.8M 2026-06
Charles River Laboratories USD 7.53B 198.16M 2026-06
Danaher USD 92.37B 8.82B 2026-06
Dentsply International USD 5.2B 25M 2026-06
General Electric Aerospace USD 127.67B 773M 2026-06
Henry Schein USD 11.38B 77M 2026-06
Illumina USD 6.65B 91M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
Mettler Toledo International USD 3.67B 2.03M 2026-06
Myriad Genetics USD 638.9M 34.8M 2026-06
OraSure Technologies USD 360.55M 18.62M 2026-06
Pacific Biosciences Of California USD 751.85M 30.51M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Repligen USD 2.95B 19.41M 2026-06
Revvity USD 12.05B 49.24M 2026-06
Standard Biotools USD 639.11M 71.36M 2026-03
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Waters USD 24.75B 220M 2026-06
West Pharmaceutical Services USD 4.08B 33.4M 2026-06